176 related articles for article (PubMed ID: 31614718)
21. [X-linked inhibitor of apoptosis protein (XIAP) and Survivin suppression on human pancreatic cancer cells Panc-1 proliferation and chemosensitivety].
Zai HY; Yi XP; Li YX; You XY; Cao LP; Liu H
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):242-9. PubMed ID: 23591345
[TBL] [Abstract][Full Text] [Related]
22. Citral induced apoptosis in MDA-MB-231 spheroid cells.
Nigjeh SE; Yeap SK; Nordin N; Kamalideghan B; Ky H; Rosli R
BMC Complement Altern Med; 2018 Feb; 18(1):56. PubMed ID: 29433490
[TBL] [Abstract][Full Text] [Related]
23. Establishment of 2D Cell Cultures Derived From 3D MCF-7 Spheroids Displaying a Doxorubicin Resistant Profile.
Nunes AS; Costa EC; Barros AS; de Melo-Diogo D; Correia IJ
Biotechnol J; 2019 Apr; 14(4):e1800268. PubMed ID: 30242980
[TBL] [Abstract][Full Text] [Related]
24. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
[TBL] [Abstract][Full Text] [Related]
25. A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer.
Moon JH; Shin JS; Hong SW; Jung SA; Hwang IY; Kim JH; Choi EK; Ha SH; Kim JS; Kim KM; Hong DW; Kim D; Kim YS; Kim JE; Kim KP; Hong YS; Choi EK; Lee JS; Hattersley M; Jin DH; Kim TW
Oncotarget; 2015 Sep; 6(29):26895-908. PubMed ID: 26314849
[TBL] [Abstract][Full Text] [Related]
26. Survivin Down-regulation by α-Santalol Is Not Mediated Through PI3K-AKT Pathway in Human Breast Cancer Cells.
Bommareddy A; Crisamore K; Fillman S; Brozena S; Steigerwalt J; Landis T; Vanwert AL; Dwivedi C
Anticancer Res; 2015 Oct; 35(10):5353-7. PubMed ID: 26408696
[TBL] [Abstract][Full Text] [Related]
27. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
28. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
[TBL] [Abstract][Full Text] [Related]
29. The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors.
Nestal de Moraes G; Castro CP; Salustiano EJ; Dumas ML; Costas F; Lam EW; Costa PR; Maia RC
Int J Oncol; 2014 Nov; 45(5):1949-58. PubMed ID: 25174716
[TBL] [Abstract][Full Text] [Related]
30. miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1.
Long J; Ji Z; Jiang K; Wang Z; Meng G
Biomed Res Int; 2015; 2015():373574. PubMed ID: 26526790
[TBL] [Abstract][Full Text] [Related]
31. Anticancer and antimetastatic activity of copper(II)-tropolone complex against human breast cancer cells, breast multicellular spheroids and mammospheres.
Balsa LM; Ruiz MC; Santa Maria de la Parra L; Baran EJ; León IE
J Inorg Biochem; 2020 Mar; 204():110975. PubMed ID: 31911364
[TBL] [Abstract][Full Text] [Related]
32. Expression of nuclear XIAP associates with cell growth and drug resistance and confers poor prognosis in breast cancer.
Delbue D; Mendonça BS; Robaina MC; Lemos LGT; Lucena PI; Viola JPB; Magalhães LM; Crocamo S; Oliveira CAB; Teixeira FR; Maia RC; Nestal de Moraes G
Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118761. PubMed ID: 32485270
[TBL] [Abstract][Full Text] [Related]
33. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
34. VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin.
Zhang L; Wang G; Wang L; Song C; Leng Y; Wang X; Kang J
Mol Cell Biochem; 2012 Feb; 361(1-2):39-45. PubMed ID: 21959976
[TBL] [Abstract][Full Text] [Related]
35. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
Chen JM; Bai JY; Yang KX
IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation.
De Iuliis F; Salerno G; Giuffrida A; Milana B; Taglieri L; Rubinacci G; Giantulli S; Terella F; Silvestri I; Scarpa S
Tumour Biol; 2016 Feb; 37(2):2603-11. PubMed ID: 26392111
[TBL] [Abstract][Full Text] [Related]
37. Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment.
Andersen AP; Flinck M; Oernbo EK; Pedersen NB; Viuff BM; Pedersen SF
Mol Cancer; 2016 Jun; 15(1):45. PubMed ID: 27266704
[TBL] [Abstract][Full Text] [Related]
38. In vitro evaluation of curcumin effects on breast adenocarcinoma 2D and 3D cell cultures.
Abuelba H; Cotrutz CE; Stoica BA; Stoica L; Olinici D; Petreuş T
Rom J Morphol Embryol; 2015; 56(1):71-6. PubMed ID: 25826489
[TBL] [Abstract][Full Text] [Related]
39. Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin.
Lee EY; Gong EY; Shin JS; Moon JH; Shim HJ; Kim SM; Lee S; Jeong J; Gong JH; Kim MJ; Lee DH; Park YS; Shin J; Hong SW; Kim YS; Jin DH
Toxicol In Vitro; 2018 Feb; 46():229-236. PubMed ID: 28947240
[TBL] [Abstract][Full Text] [Related]
40. Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells.
Zhen MC; Wang FQ; Wu SF; Zhao YL; Liu PG; Yin ZY
Oncotarget; 2017 Feb; 8(6):9466-9475. PubMed ID: 28036295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]